Industry News
Single Session Of Relaxation Response Practice Alters Gene Expression Involved In Inflammation, Energy Metabolism, Insulin Secretion
May 03, 2013
A new study from investigators at the Benson-Henry Institute for Mind/Body Medicine at Massachusetts General Hospital (MGH) and Beth Israel Deaconess Medical Center (BIDMC) finds that elicitation of the relaxation response - a physiologic state of deep rest induced by practices such as meditation, yoga, deep breathing and prayer - produces immediate changes in the expression of... Read More
The Up And Down Side Of 'Traffic' In Our Cells
May 03, 2013
A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negative aspect prevents vital drugs, such as anti-cancer drugs, from achieving their designed functions, while also enabling bacterial cells to develop resistance to penetration of antibiotics... Read More
In Oropharyngeal Squamous Cell Carcinoma, HPV Leaves Its Mark
May 03, 2013
Oropharyngeal squamous cell carcinoma (OPSCC) is a form of cancer that affects the cells lining the middle part of the throat, including the soft palate, the base of the tongue, the tonsils, and the pharynx... Read More
Dabigatran Etexilate (Pradaxa) And Intracranial Hemorrhage
May 03, 2013
The Journal of Neurosurgery Publishing Group is pleased to announce publication of two new studies on dabigatran etexilate (Pradaxa®) and intracranial hemorrhage: one in the Journal of Neurosurgery and the other in Neurosurgical Focus... Read More
Discovery Of Mutation Driving Pediatric Brain Tumors
May 03, 2013
A type of low-grade but sometimes lethal brain tumor in children has been found in many cases to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors, report scientists at Dana-Farber Cancer Institute... Read More
OncoGenex Announces That The Borealis-2(TM) Clinical Trial Of OGX-427 In Previously Treated Metastatic Bladder Cancer Is Now Open For Enrollment
May 02, 2013
The OGX-427 ORCA™ Program Continues to Expand with Patient Enrollment Now Open for Second Phase 2 Trial of OGX-427 in Advanced Bladder Cancer OncoGenex Pharmaceuticals, Inc... Read More
UF Researchers Develop 'Nanotrain' For Targeted Cancer Drug Transport
May 02, 2013
University of Florida researchers have developed a "DNA nanotrain" that fast-tracks its payload of cancer-fighting drugs and bioimaging agents to tumor cells deep within the body... Read More
New DNA Blood Test Could Increase Access To Herceptin
May 02, 2013
A new blood test for women with breast cancer could identify more women who will benefit from the targeted treatment Herceptin without the need for uncomfortable biopsies. The new 'liquid biopsy' uses cutting-edge genetic techniques to detect breast cancer DNA in the bloodstream, and was developed by a team at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust... Read More
Dogs Can Detect Breast And Lung Cancer Cells In Vitro
May 02, 2013
Researcher Hopes to Screen Smokers with Early Stage Lung Disease in Next Research Phase An internist and instructor at Ben-Gurion University of the Negev has conducted research proving that specially trained dogs can differentiate the smell of breast cancer cells from non-cancerous cells in cell cultures... Read More
First Comprehensive Analysis Reveals Long-term Effectiveness Of SERMs For Preventing Breast Cancer
May 02, 2013
Selective oestrogen receptor modulators (SERMs: tamoxifen, raloxifene, arzoxifene, and lasofoxifene) significantly reduce the risk of developing the most common type of breast cancer among women at both high and average risk of the disease* both during treatment, and for at least 5 years after stopping, according to the first comprehensive analysis of all SERM prevention trials... Read More
Previous Page Next Page